Stockscreener 앱 받기
45.06
5.75%
2.455
전일 마감가:
$42.61
열려 있는:
$43.53
하루 거래량:
1.86M
Relative Volume:
1.18
시가총액:
$2.88B
수익:
-
순이익/손실:
$-218.28M
주가수익비율:
-12.59
EPS:
-3.5803
순현금흐름:
$-186.55M
1주 성능:
+33.51%
1개월 성능:
+86.97%
6개월 성능:
+47.11%
1년 성능:
-6.34%
1일 변동 폭
$43.34
$46.17
1주일 범위
$32.66
$46.17
52주 변동 폭
$18.53
$49.77
베라 테라 Stock (VERA) Company Profile
명칭
Vera Therapeutics Inc
전화
650-770-0077
주소
2000 SIERRA POINT PARKWAY, SUITE 1200, BRISBANE
VERA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
VERA
Vera Therapeutics Inc
|
45.08 | 2.72B | 0 | -218.28M | -186.55M | -3.5803 |
|
VRTX
Vertex Pharmaceuticals Inc
|
455.17 | 116.04B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
720.87 | 75.97B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
460.00 | 61.48B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
903.20 | 56.40B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
204.54 | 43.73B | 447.02M | -1.18B | -906.14M | -6.1812 |
베라 테라 Stock (VERA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-10-16 | 개시 | BofA Securities | Buy |
| 2025-08-04 | 다운그레이드 | Wolfe Research | Outperform → Peer Perform |
| 2025-05-05 | 재개 | H.C. Wainwright | Buy |
| 2025-02-04 | 개시 | Wolfe Research | Outperform |
| 2025-01-28 | 개시 | Goldman | Buy |
| 2024-11-21 | 개시 | Wells Fargo | Overweight |
| 2024-10-16 | 개시 | Scotiabank | Sector Outperform |
| 2024-01-25 | 개시 | Oppenheimer | Outperform |
| 2024-01-08 | 개시 | Cantor Fitzgerald | Overweight |
| 2023-12-18 | 개시 | Raymond James | Outperform |
| 2023-11-10 | 업그레이드 | Jefferies | Hold → Buy |
| 2023-08-16 | 개시 | Guggenheim | Buy |
| 2023-01-04 | 다운그레이드 | Jefferies | Buy → Hold |
| 2023-01-04 | 다운그레이드 | Wedbush | Outperform → Neutral |
| 2022-07-12 | 개시 | JP Morgan | Overweight |
| 2022-05-02 | 개시 | H.C. Wainwright | Buy |
| 2022-04-19 | 개시 | Wedbush | Outperform |
모두보기
베라 테라 주식(VERA)의 최신 뉴스
Vera Therapeutics Inc. (VERA) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Schroder Investment Management Group Reduces Stock Position in Vera Therapeutics, Inc. $VERA - MarketBeat
Vera Therapeutics stock price target raised to $73 from $60 at TD Cowen - Investing.com UK
Vera Therapeutics exec Turner sells $400k in shares - Investing.com
Vera Therapeutics exec Turner sells $400k in shares By Investing.com - Investing.com UK
Vera Therapeutics Executive Sells 10,000 Shares - TradingView
Will Vera Therapeutics Inc. stock reach Wall Street targets2025 Institutional Moves & Consistent Growth Stock Picks - Newser
Why Vera Therapeutics Inc. stock is trending among retail tradersMarket Volume Summary & Short-Term Trading Opportunity Alerts - Newser
Is Vera Therapeutics’ Recent 69% Surge Justified by Its Valuation in 2025? - Yahoo Finance
Vera Therapeutics rises 19.2% - MSN
Vera Therapeutics Stock Soars: Time to Buy? - StocksToTrade
Vera Therapeutics (VERA): Reassessing Valuation After Positive Phase 3 IgAN Data and Accelerated FDA Path - Yahoo Finance
Is Vera Therapeutics (VERA) Quietly Recasting Its Commercial Strategy With the Meyers Board Appointment? - Yahoo Finance
Vera Therapeutics (NASDAQ:VERA) Stock Price Up 6.7%Here's What Happened - MarketBeat
Vera Therapeutics, Inc. (VERA): A Top Gainer with Promising FDA Approvals - Meyka
Vera Therapeutics: Stock Rises As IgAN Approval Chances IncreaseI'm On Sidelines (VERA) - Seeking Alpha
American Century Companies Inc. Raises Position in Vera Therapeutics, Inc. $VERA - MarketBeat
Why Vera Therapeutics Stock Rocked the Market on Tuesday - Finviz
Vera Therapeutics stock price target reiterated at $73 by Raymond James - Investing.com Canada
Vera’s Surge: What It Means For Investors - timothysykes.com
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
Quadrature Capital Ltd Invests $852,000 in Vera Therapeutics, Inc. $VERA - MarketBeat
Why Vera Therapeutics Inc. stock is recommended by analystsWeekly Profit Summary & Safe Entry Trade Reports - Newser
Discipline and Rules-Based Execution in VERA Response - news.stocktradersdaily.com
Will Vera Therapeutics (VERA) Strengthen Its Commercial Edge With Board Appointment of James R. Meyers? - Sahm
Vera Therapeutics Contributes To Nasdaq Index Growth In Biotech - Kalkine Media
KDIGO guidelines positive for Vera Therapeutics, says Cantor Fitzgerald - MSN
XTX Topco Ltd Grows Position in Vera Therapeutics, Inc. $VERA - MarketBeat
A Fresh Look at Vera Therapeutics (VERA) Valuation as Analyst Optimism Follows Board Addition and FDA Milestone - Sahm
Geode Capital Management LLC Increases Stock Holdings in Vera Therapeutics, Inc. $VERA - MarketBeat
Vera Therapeutics stock steady as H.C. Wainwright reiterates Buy rating By Investing.com - Investing.com Canada
Wolfe Research Initiates Coverage of Vera Therapeutics (VERA) with Outperform Recommendation - MSN
Polycythemia Vera Pipeline 2025: MOA and ROA Insights, Clinical - openPR.com
Earnings Report: Is Vera Therapeutics Inc. stock a top momentum play2025 Short Interest & AI Based Buy and Sell Signals - BỘ NỘI VỤ
Vera Therapeutics (NASDAQ:VERA) Stock Price Up 11.8%Should You Buy? - MarketBeat
Vera Thera files BLA for atacicept in IgAN - The Pharma Letter
Why Vera Therapeutics Stock Crushed it Today - Finviz
Vera Therapeutics appoints former Gilead executive to board By Investing.com - Investing.com Nigeria
Vera Therapeutics Appoints James R. Meyers to Board - TipRanks
Vera Therapeutics Stock Unveiled: What Lies Ahead? - timothysykes.com
Vera Therapeutics Form 4 shows 25,000 director stock options - Stock Titan
New Vera Therapeutics (VERA) director reports zero beneficial ownership - Stock Titan
Vera Therapeutics Appoints James R. Meyers to Board of Directors - TradingView
Vera Therapeutics appoints James R. Meyers director and audit member - Stock Titan
Vera Therapeutics appoints former Gilead executive to board - Investing.com
Vera Therapeutics Appoints Biopharmaceutical Veteran James R. Meyers to Board of Directors - Quiver Quantitative
Vera Therapeutics Appoints Veteran Biotech Executive James R. Meyers to its Board of Directors - GlobeNewswire
After pivot, this Bay Area CEO says company is hiring and 'almost to the starting line'San Francisco Business Times - The Business Journals
Vera Therapeutics stock undervalued with strong IgAN market potential By Investing.com - Investing.com UK
Vera Therapeutics Reports Increased Losses Amid R&D Expansion - MSN
Vera Therapeutics Executive Sells Shares to Cover Tax Obligations - TradingView
베라 테라 (VERA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
베라 테라 주식 (VERA) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Turner William D. | Chief Regulatory Officer |
Dec 03 '25 |
Sale |
40.00 |
10,000 |
400,000 |
22,500 |
0.77%
0.84%
자본화:
|
볼륨(24시간):